Scarica l'app Stockscreener
97.92
2.76%
-2.78
Dopo l'orario di chiusura:
98.06
0.14
+0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$100.70
Aprire:
$100.47
Volume 24 ore:
15.31M
Relative Volume:
1.52
Capitalizzazione di mercato:
$251.88B
Reddito:
$63.17B
Utile/perdita netta:
$12.15B
Rapporto P/E:
20.53
EPS:
4.77
Flusso di cassa netto:
$14.84B
1 W Prestazione:
-1.34%
1M Prestazione:
-2.14%
6M Prestazione:
-22.22%
1 anno Prestazione:
-17.11%
Intervallo 1D:
$97.92
$100.47
Intervallo di 1 settimana:
$97.92
$101.49
Portata 52W:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Merck: 3x Pipeline And Undervaluation Make It A Buy (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
AHL Investment Management Inc. Invests $269,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Annex Advisory Services LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Brady Martz Wealth Solutions LLC Acquires Shares of 17,939 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Ameritas Advisory Services LLC - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’ - Insider Monkey
Folger Nolan Fleming Douglas Capital Management Inc. Has $6.91 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wealth Alliance Advisory Group LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kera Capital Partners Inc. Purchases New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jackson Square Capital LLC Sells 15,684 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
HB Wealth Management LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Integrated Investment Consultants LLC Has $62.33 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Lifted by Merit Financial Group LLC - MarketBeat
Arkadios Wealth Advisors Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Moderna Stock a Buy? - The Motley Fool
How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks? - MSN
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025? - Insider Monkey
Exclusive: Kennedy played key role in Gardasil vaccine case against Merck - Reuters
Householder Group Estate & Retirement Specialist LLC Sells 4,613 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Relyea Zuckerberg Hanson LLC Purchases 3,131 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hennessy Advisors Inc. Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Carnegie Investment Counsel - MarketBeat
Yarger Wealth Strategies LLC Invests $252,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Stock Price | MRK Stock Quote, News, and History - Markets Insider
Purdue teams with Lilly, Merck to launch pharma manufacturing initiative - Inside INdiana Business
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Guggenheim cuts Merck stock target, retains Buy on revised estimates - MSN
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
KMG Fiduciary Partners LLC Acquires 14,161 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Empirical Asset Management LLC Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Salvus Wealth Management LLC - MarketBeat
Tallon Kerry Patrick Acquires Shares of 3,679 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.
Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case - Law360
Godsey & Gibb Inc. Acquires 9,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Business Wire
Campbell Newman Asset Management Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Wolff Wiese Magana LLC Acquires 4,633 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Founders Grove Wealth Partners LLC Buys New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Assenagon Asset Management S.A. Sells 1,440,399 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Down Very Badly’ - Insider Monkey
Who Are Pfizer's (PFE) Main Competitors? - Investopedia
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Trimmed by Park Avenue Securities LLC - MarketBeat
Price Over Earnings Overview: Merck & Co - Benzinga
Pines Wealth Management LLC Buys New Shares in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Rockland Trust Co. Buys 30,562 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Horizon Bancorp Inc. IN Buys 9,938 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):